🇺🇸 FDA
Patent

US 9006399

Anti-OX40 antibodies and methods of using the same

granted A61KA61K2039/505A61P

Quick answer

US patent 9006399 (Anti-OX40 antibodies and methods of using the same) held by The Board of Regents of the University of Texas System expires Mon Apr 09 2035 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The Board of Regents of the University of Texas System
Grant date
Tue Apr 14 2015 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Apr 09 2035 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
9
CPC classes
A61K, A61K2039/505, A61P, A61P35/00, A61P37/00